oseltamivir has been researched along with Infections, Respiratory in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (10.26) | 29.6817 |
| 2010's | 30 (76.92) | 24.3611 |
| 2020's | 5 (12.82) | 2.80 |
| Authors | Studies |
|---|---|
| Carrico, RM; Fry, AM; Furmanek, SP; Hoft, D; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
| Friedman, JN; Ostrow, O; Richardson, SE; Savlov, D | 1 |
| Berenger, BM; Bibby, HL; Church, DL; de Koning, L; Seiden-Long, I; Zelyas, N | 1 |
| Chi, S; Li, H; Qin, X; Sun, C; Wang, Y; Wu, L | 1 |
| Bont, LJ; Löwensteyn, YN | 1 |
| Guan, Y; Han, Y; Song, C; Yang, J; Zhang, X; Zheng, L | 1 |
| Cleghorn, S | 1 |
| Cooper, MJ; Darling, N; Doepking, M; Harris, S; Hawksworth, AW; Kremer, P; Myers, CA; Sanchez, JL; Steiner, SC; Swanson, KC | 1 |
| Liese, JG; Prifert, C; Sauerbrei, A; Schmidt-Ott, R; Streng, A; Weissbrich, B | 1 |
| Chaves, SS; Fry, AM; Peyrani, P; Ramirez, J; Wiemken, T | 1 |
| Adams, EJ; Cheng, CY; Douthwaite, ST; Glover, RE; Goldenberg, SD; Mak, C; Vecino-Ortiz, AI | 1 |
| Carballal, G; Echavarría, M; Ekstrom, J; Marcone, DN; O'Farrell, C; Querci, M; Seoane, A; Vidaurreta, S; Videla, C; Ypas, M | 1 |
| Hassan, F; Jackson, MA; Lee, BR; Selvarangan, R | 1 |
| Beale, DJ; Dunn, MS; Hurt, AC; Karpe, AV; Oh, DY; Palombo, EA; Tai, C; Tilmanis, D | 1 |
| Hoepelman, AIM; Kaasjager, KHAH; Oosterheert, JJ; Riezebos-Brilman, A; Vos, LM; Weehuizen, JM | 1 |
| Gabriel, G; Klingen, TR; Loers, J; McHardy, AC; Stanelle-Bertram, S | 1 |
| Fu, Q; Li, J; Mei, D; Wen, LP; Zhang, B; Zuo, W | 1 |
| Covello, LHS; Da Silva Teixeira, RER; de Godoy, LG; de Oliveira, NE; Dutra, KR; Frini, ICM; Furlan, NP; Gandolfi, JV; Lobo, SM; Nogueira, ML; Queiroz, F; Sacillotto, GH; Salomão, MLM; Simões, ES; Watanabe, ASA | 1 |
| Biggs, M; Bradley, CW; Carmalt, S; Garvey, MI; Holden, E; Osman, H; Reddy-Kolanu, V; Wilkinson, MAC | 1 |
| Adamou, E; Chen, X; Conrad, T; Hoppe, C; Karsch, K; Muehlhans, S; Obermeier, P; Peiser, C; Rath, B; Schweiger, B; Seeber, L; Tief, F; von Kleist, M | 1 |
| Badrul, AS; Chee Kheong, C; Fadzilah, K; Hirman, I; Lokman Hakim, S; Noor Hisham, A; Noraini, W; Norhayati, R; Premila Devi, J; Zainah, S | 1 |
| Boonlayangoor, S; Brielmaier, B; Charnot-Katsikas, A; Matushek, S; Pettit, NN; Pisano, J; Tesic, V | 1 |
| Chesnokov, AP; Davis, CT; De La Cruz, JA; Fry, AM; Gubareva, LV; Marjuki, H; Mishin, VP; Villanueva, JM | 1 |
| Fry, AM; McKimm-Breschkin, JL | 1 |
| Heikkinen, T | 1 |
| Campbell, SM; Green, DA; Hitoaliaj, L; Kotansky, B; Peaper, DR | 1 |
| Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
| Beerens, N; Bestebroer, TM; Cotten, M; de Jonge, HC; de Kleer, I; Fouchier, RA; Fraaij, PL; Hoebe, CJ; Houmes, RJ; Koopmans, MP; Oude Munnink, BB; Pas, SD; Phan, MV; Roosenhoff, RS; Swaan, CM; Timen, A; Tolsma, P; van den Kerkhof, JH; van Kampen, JJ; Wildschut, ED | 1 |
| Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
| Blair, J; Burton, L; Choi, K; De Lima, C; Drews, SJ; Eshaghi, A; Lombos, E | 1 |
| Claas, EC; Gooskens, J; Jonges, M; Kroes, AC; Meijer, A | 1 |
| Baracat, EC; Fraga, AM; Miranda, ML; Omae, CC; Pereira, RM; Reis, MC; Romaneli, MT; Tresoldi, AT | 1 |
| Chang, CM; Chang, YS; Huang, FC; Lai, CC; Li, ML; Tseng, SH | 1 |
| Gutierrez, C; Nazar, GA; Torres, JP | 1 |
| Chan, ES; Ip, M; Lee, NL; Leung, MY; You, JH | 1 |
| Brydak, LB; Donevski, S; Gawryluk, D; Romanowska, M; Stefanska, I | 1 |
| Benjamin, JH; Gardner, C; Green, K; Lee, W; Loeb, M; McArthur, M; McGeer, AJ; Simor, AE | 1 |
| Hayden, FG | 1 |
4 review(s) available for oseltamivir and Infections, Respiratory
| Article | Year |
|---|---|
EMERGING PATHOGENS: INFLUENZA - H7N9.
Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Cough; Fever; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Oseltamivir; Poultry; Radiography, Thoracic; Respiratory Distress Syndrome; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Eustachian Tube; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Interferon-beta; Oseltamivir; Otitis Media; Otitis Media with Effusion; Picornaviridae Infections; Piperidines; Pressure; Pyrans; Pyridazines; Respiratory Tract Infections; Rhinovirus; Rimantadine; Sialic Acids; Superinfection; Virus Replication; Zanamivir | 2000 |
4 trial(s) available for oseltamivir and Infections, Respiratory
| Article | Year |
|---|---|
Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection.
Topics: Adult; Antiviral Agents; Humans; Influenza, Human; Oseltamivir; Respiratory Tract Infections; Treatment Outcome | 2021 |
A pragmatic randomized controlled trial of rapid on-site influenza and respiratory syncytial virus PCR testing in paediatric and adult populations.
Topics: Adult; Anti-Bacterial Agents; Child; Humans; Influenza, Human; Oseltamivir; Polymerase Chain Reaction; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Viruses | 2022 |
A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hospitalization; Humans; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Prospective Studies; Respiratory Tract Infections; Time-to-Treatment; Treatment Failure; Treatment Outcome | 2018 |
Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Emergency Service, Hospital; Female; Fluorescent Antibody Technique; Humans; Inappropriate Prescribing; Infant; Male; Middle Aged; Multiplex Polymerase Chain Reaction; Oligonucleotide Array Sequence Analysis; Oseltamivir; Prospective Studies; Respiratory Tract Infections; Virus Diseases; Viruses; Young Adult | 2018 |
31 other study(ies) available for oseltamivir and Infections, Respiratory
| Article | Year |
|---|---|
Reducing Unnecessary Respiratory Viral Testing to Promote High-Value Care.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Microbial Sensitivity Tests; Ontario; Oseltamivir; Quality Improvement; Respiratory Tract Infections; Viral Load | 2022 |
Use of MRI in the diagnosis and prognosis of acute necrotizing encephalopathy in a Chinese teenager: A case report.
Topics: Adolescent; Adrenal Cortex Hormones; Antiviral Agents; Brain; China; Encephalitis, Viral; Female; Humans; Magnetic Resonance Imaging; Necrosis; Oseltamivir; Prognosis; Respiratory Tract Infections; Seizures | 2019 |
Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir.
Topics: Antiviral Agents; Double-Blind Method; Hematopoietic Stem Cell Transplantation; Humans; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Transplant Recipients | 2020 |
Risks in clinical applications of oseltamivir phosphate in the real world.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Dose-Response Relationship, Drug; Female; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Young Adult | 2020 |
Highlights from IDWeek 2017.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteremia; beta-Lactamases; Clostridioides difficile; Cystitis; Drinking; Drug Administration Schedule; Dysbiosis; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Respiratory Tract Infections; Staphylococcal Infections | 2017 |
Outbreak of influenza and rhinovirus co-circulation among unvaccinated recruits, U.S. Coast Guard Training Center Cape May, NJ, 24 July-21 August 2016.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adult; Antiviral Agents; Coinfection; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Male; Military Personnel; New Jersey; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rhinovirus; Young Adult | 2018 |
Subtype-specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children 1-5 Years of Age Treated in Outpatient Practices in Germany During Three Postpandemic Years, 2013-2015.
Topics: Antiviral Agents; Bronchitis; Child, Preschool; Epidemiological Monitoring; Female; Fever; Germany; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Male; Multiplex Polymerase Chain Reaction; Oseltamivir; Outpatients; Pandemics; Pharyngitis; Prospective Studies; Respiratory Tract Infections; Seasons | 2018 |
Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Diagnostic Tests, Routine; England; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza B virus; Inpatients; Male; Multiplex Polymerase Chain Reaction; Oseltamivir; Point-of-Care Systems; Respiratory Syncytial Virus, Human; Respiratory Tract Infections | 2018 |
Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Child, Preschool; Critical Pathways; Disease Management; Drug Utilization; Hospitalization; Humans; Infant; Influenza, Human; Inpatients; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Oseltamivir; Respiratory Tract Infections; Retrospective Studies; Time Factors | 2019 |
Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment.
Topics: Animals; Antiviral Agents; Ferrets; Gas Chromatography-Mass Spectrometry; Influenza A virus; Metabolomics; Orthomyxoviridae Infections; Oseltamivir; Respiratory System; Respiratory Tract Infections | 2019 |
More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients.
Topics: Aged; Antiviral Agents; Emergency Service, Hospital; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Molecular Diagnostic Techniques; Oseltamivir; Patient Isolation; Reagent Kits, Diagnostic; Respiratory Tract Infections; Viruses | 2019 |
Structures and functions linked to genome-wide adaptation of human influenza A viruses.
Topics: Drug Resistance, Viral; Evolution, Molecular; Genome, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Oseltamivir; Respiratory Tract Infections; Viral Nonstructural Proteins; Virus Replication | 2019 |
Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report.
Topics: Antiviral Agents; Child; Female; HLA-A2 Antigen; Humans; Oseltamivir; Respiratory Tract Infections; Stevens-Johnson Syndrome | 2019 |
Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness.
Topics: Adult; Aged; Antiviral Agents; Female; Hospital Mortality; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiratory Distress Syndrome; Respiratory Tract Infections; Risk Factors; Time-to-Treatment | 2019 |
Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study.
Topics: Drug Prescriptions; Hospitalization; Hospitals, Teaching; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Length of Stay; Oseltamivir; Point-of-Care Testing; Polymerase Chain Reaction; Quarantine; Respiratory Tract Infections; Time-to-Treatment; United Kingdom | 2019 |
Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.
Topics: Antiviral Agents; Child; Child, Preschool; Coinfection; Drug Resistance, Viral; Early Diagnosis; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Patient Isolation; Precision Medicine; Respiratory Tract Infections; Viral Proteins | 2013 |
Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014.
Topics: Antiviral Agents; Communicable Disease Control; Contact Tracing; Coronavirus; Coronavirus Infections; Disease Notification; Fatal Outcome; Humans; Malaysia; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Saudi Arabia; Syndrome; Travel | 2014 |
Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies.
Topics: Antiviral Agents; Early Diagnosis; Humans; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Oseltamivir; Reagent Kits, Diagnostic; Respiratory Tract Infections; Time Factors; Virus Diseases; Viruses | 2015 |
Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Resistance, Viral; Enzyme Inhibitors; Ferrets; Genes, Viral; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Male; Mutation; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Respiratory Tract Infections; Virus Replication | 2015 |
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rimantadine; Severe Acute Respiratory Syndrome; Texas; Virus Replication | 2016 |
Respiratory viruses and children.
Topics: Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Cost of Illness; Humans; Influenza, Human; Oseltamivir; Otitis Media; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Viral Vaccines; Virus Diseases | 2016 |
Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Bacterial Agents; Asthma; Emergency Service, Hospital; Female; Humans; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Oseltamivir; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Retrospective Studies | 2016 |
Severe acute respiratory infection caused by swine influenza virus in a child necessitating extracorporeal membrane oxygenation (ECMO), the Netherlands, October 2016.
Topics: Animals; Antiviral Agents; Extracorporeal Membrane Oxygenation; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units, Pediatric; Netherlands; Orthomyxoviridae Infections; Oseltamivir; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections; Severe Acute Respiratory Syndrome; Swine; Swine Diseases; Treatment Outcome | 2016 |
A paucity of co-infecting respiratory viral pathogens in nasopharyngeal specimens from patients infected with H274Y-positive influenza A (H1N1) strains.
Topics: Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Nasopharynx; Neuraminidase; Ontario; Oseltamivir; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Viral Proteins; Virus Diseases; Viruses | 2009 |
Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Gene Amplification; Humans; Immunocompromised Host; Infant; Influenza A virus; Influenza A Virus, H3N2 Subtype; Influenza, Human; Lymphopenia; Microbial Sensitivity Tests; Middle Aged; Netherlands; Oseltamivir; Respiratory Tract Infections; Retrospective Studies; RNA, Viral; Virus Shedding | 2009 |
Clinical features and outcome of children and adolescents hospitalized with influenza A (H1N1) virus infection compared with flu-like symptoms and negative rapid tests for influenza A (H1N1) admitted in the same period of time.
Topics: Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Critical Care; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Male; Oseltamivir; Respiration, Artificial; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2011 |
Acute anterior uveitis and optic neuritis as ocular complications of influenza A infection in an 11-year-old boy.
Topics: Acute Disease; Administration, Topical; Antiviral Agents; Child; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Male; Methylprednisolone; Optic Neuritis; Oseltamivir; Prednisolone; Pulse Therapy, Drug; Respiratory Tract Infections; Tomography, Optical Coherence; Uveitis, Anterior | 2011 |
Otolaryngological complications in patients infected with the influenza A (H1N1) virus.
Topics: Adolescent; Age Distribution; Anti-Bacterial Agents; Child; Child, Preschool; Chile; Cohort Studies; Comorbidity; Emergency Service, Hospital; Female; Hospitalization; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Otitis Media; Pandemics; Respiratory Tract Infections; Retrospective Studies; Rhinitis; Severity of Illness Index; Sex Distribution; Sinusitis; Tonsillitis; Treatment Outcome; Young Adult | 2012 |
A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong.
Topics: Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Fluorescent Antibody Technique; Hong Kong; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Models, Economic; Monte Carlo Method; Oseltamivir; Outcome Assessment, Health Care; Polymerase Chain Reaction; Prevalence; Quality-Adjusted Life Years; Respiratory Tract Infections | 2012 |
Co-infections with influenza and other respiratory viruses.
Topics: Adult; Aged; Alphainfluenzavirus; Antiviral Agents; Child, Preschool; Coinfection; Coronavirus; Coronavirus Infections; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections | 2013 |
Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Child; Comorbidity; Developmental Disabilities; Disease Outbreaks; Female; Gastrointestinal Diseases; Humans; Incidence; Infection Control; Long-Term Care; Male; Middle Aged; Nervous System Diseases; Ontario; Oseltamivir; Respiratory Tract Infections; Severity of Illness Index | 2004 |